Thomas Jefferson University

Jefferson Digital Commons
Department of Dermatology and Cutaneous
Biology Faculty Papers

Department of Dermatology and Cutaneous
Biology

5-25-2020

Characteristics of Nontuberculous Mycobacterial Infections at a
Midwestern Tertiary Hospital: A Retrospective Study of 365
Patients.
Claire E Hannah
Department of Internal Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA, United
States

Bradley A Ford
Department of Pathology, University of Iowa Hospitals and Clinics, Iowa City, IA, United States

Jina Chung
Department of Dermatology, Thomas Jefferson University, Philadelphia, PA, United States
Follow this and additional works at: https://jdc.jefferson.edu/dcbfp

Dilek Ince

Department
of Dermatology
Internal Medicine,
Division of Infectious Diseases, University of Iowa Hospitals and Clinics,
Part of the
Commons
Iowa City, IA, United States

Let us know how access to this document benefits you
Karolyn A Wanat
Department of Dermatology, Medical College of Wisconsin, Milwaukee, WI, United States

Recommended Citation
Hannah, Claire E; Ford, Bradley A; Chung, Jina; Ince, Dilek; and Wanat, Karolyn A, "Characteristics
of Nontuberculous Mycobacterial Infections at a Midwestern Tertiary Hospital: A Retrospective
Study of 365 Patients." (2020). Department of Dermatology and Cutaneous Biology Faculty
Papers. Paper 149.
https://jdc.jefferson.edu/dcbfp/149
This Article is brought to you for free and open access by the Jefferson Digital Commons. The Jefferson Digital
Commons is a service of Thomas Jefferson University's Center for Teaching and Learning (CTL). The Commons is
a showcase for Jefferson books and journals, peer-reviewed scholarly publications, unique historical collections
from the University archives, and teaching tools. The Jefferson Digital Commons allows researchers and interested
readers anywhere in the world to learn about and keep up to date with Jefferson scholarship. This article has been
accepted for inclusion in Department of Dermatology and Cutaneous Biology Faculty Papers by an authorized
administrator of the Jefferson Digital Commons. For more information, please contact:
JeffersonDigitalCommons@jefferson.edu.

Open Forum Infectious Diseases
MAJOR ARTICLE

Characteristics of Nontuberculous Mycobacterial
Infections at a Midwestern Tertiary Hospital:
A Retrospective Study of 365 Patients
Claire E. Hannah,1, Bradley A. Ford,2 Jina Chung,3 Dilek Ince,4 and Karolyn A. Wanat,5
1
Department of Internal Medicine, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, USA, 2Department of Pathology, University of Iowa Hospitals and Clinics, Iowa City, Iowa,
USA, 3Department of Dermatology, Thomas Jefferson University, Philadelphia, Pennsylvania, USA, 4Department of Internal Medicine, Division of Infectious Diseases, University of Iowa Hospitals
and Clinics, Iowa City, Iowa, USA, 5Department of Dermatology, Medical College of Wisconsin, Milwaukee, Wisconsin, USA

Background. The prevalence of infections due to nontuberculous mycobacteria (NTM) is increasing worldwide, yet little is
known about the epidemiology and pathophysiology of these ubiquitous environmental organisms. Pulmonary disease due to
Mycobacterium avium complex is most prevalent, but many other NTM species can cause disease in virtually any organ system. As
NTM becomes an increasingly common cause of morbidity and mortality, more information is needed about the epidemiology of
NTM disease.
Methods. We conducted a retrospective chart review of all patients with cultures that grew NTM at a Midwestern tertiary hospital from 1996 to 2017. Information on demographics, medical history, clinical findings, treatment, and outcome was obtained from
medical records of all NTM isolates. American Thoracic Society/Infectious Diseases Society of America criteria were used to define
pulmonary NTM infections.
Results. We identified 1064 NTM isolates, 365 of which met criteria for NTM infection. Pulmonary cases predominated (185 of
365; 50.7%), followed by skin/soft tissue (56 of 365; 15.3%), disseminated (40 of 365; 11%), and lymphatic (28 of 365; 7.7%) disease.
Mycobacterium avium complex was the most common species (184 of 365; 50.4%). Individuals aged >50 years were most affected
(207 of 365; 56.7%). Common comorbidities included structural lung disease (116 of 365; 31.8%), use of immunosuppressive medications (78 of 365; 21.4%), malignancy (59 of 365; 16.2%), and human immunodeficiency virus (42 of 365; 11.5%).
Conclusions. This large cohort provides information on the demographics, risk factors, and disease course of patients with
pulmonary and extrapulmonary NTM infections. Most patients had medical comorbidities that resulted in anatomic, genetic, or
immunologic risk factors for NTM infection. Further population-based studies and increased disease surveillance are warranted to
further characterize NTM infection prevalence and trends.
Keywords. atypical mycobacteria; nontuberculous mycobacteria.
Nontuberculous mycobacteria (NTM), generally defined as
mycobacteria not in the Mycobacterium tuberculosis complex
(MTC) and other than Mycobacterium leprae, represent a diverse and emerging group of pathogens that cause disease in
both immunocompromised and immunocompetent people [1].
Nontuberculous mycobacteria are ubiquitous in the environment and are thought to be acquired through exposure to water,
soil, animals, plants, and food sources [2, 3]. Nontuberculous
mycobacteria infections can involve any organ system but most
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commonly manifest as pulmonary disease, skin/soft tissue infection (SSTI), and lymphadenitis [1]. Higher rates of infection
are seen in patients with underlying anatomic/structural organ
abnormalities (eg, cystic fibrosis, bronchiectasis, emphysema)
or immunodeficiency (eg, human immunodeficiency virus
[HIV], organ transplant, immunosuppressive medications) [2,
3]. Often, NTM infections present insidiously and mimic other
conditions, resulting in delayed diagnosis and significant morbidity and mortality [4]. Treatment methods and success rates
vary depending on the organism and disease site.
The incidence of NTM infection is likely increasing at a steep
rate [5]. Brode et al [6] found that although rates of tuberculosis are declining in many countries, infection and death from
NTM are rising. In the 1980s, NTM disease prevalence was reported at 1.6 to 1.8 per 100 000 people, whereas recent studies
have shown a prevalence of 14.1 per 100 000 in North America
[4]. These infections disproportionately affect the elderly, suggesting that NTM disease will become even more common
as the population ages [4]. With increasing NTM-related
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morbidity and mortality worldwide, more epidemiologic information is needed to guide diagnosis and management. In the
United States, population-based data are lacking, partly because
NTM are not reportable to public health authorities [7]. Much
of the available data comes from laboratory-based surveillance,
which does not provide the clinical or radiographic information needed to distinguish true infection from colonization or
contamination. In this study, thorough medical record review
was performed on all patients with NTM culture isolates at a
Midwestern tertiary hospital from 1996 to 2017. We collected
clinical, radiographic, and microbiologic data from medical
records to identify cases of true NTM infection and further
characterize patient demographics, clinical manifestations,
risk factors, treatment, and outcomes for these increasingly
common infections.
METHODS
Study Design

We conducted a retrospective medical record review of all patients with at least 1 positive NTM culture at the University of
Iowa Hospitals and Clinics in Iowa City, Iowa between January
1, 1996 and May 31, 2017. Patients of all ages were eligible
for inclusion. Complete paper records of final, definitive identifications for all positive mycobacterial cultures were kept
through the study period and were used to identify patients
for chart review. All chart review data were obtained from hospital electronic health records. The study was approved by the
hospital’s institutional review board. During the period covered by this review, the number of hospital beds stayed essentially the same at approximately 820, but the number of clinics
expanded from approximately 30 to 300. The University of
Iowa serves a population of several million as the only academic institution in the state.
Laboratory Methods

Samples were decontaminated with reagents created by an
in-house reagent laboratory, and primary samples and positive cultures were stained with both Auramine-Rhodamine
and Ziehl-Neelsen. Blood cultures were collected in BACTEC
12B/13A bottles, BACTEC MYCO/F Lytic bottles, or (rarely)
Isolator tubes transferred to primary media (Lowenstein-Jensen
and 7H10 or 7H11 media). Other broth cultures were performed on the BACTEC MGIT 960 system. Sterile material was
ground and transferred to these solid media. Solid media were
incubated at 37°C in 5%–10% CO2. Skin, connective tissue,
joint, and bone specimens were also incubated at 30°C, with an
X-factor disk included to recover Mycobacterium haemophilum.
Standard incubation was for ≥6 weeks; positive acid-fast bacillus smears that were culture negative at 6 weeks were held
for an additional 4 weeks, and if Mycobacterium ulcerans was
suspected, cultures were incubated for 8 weeks. Mycobacterium
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xenopi, which grows only slightly faster at 42°C versus 37°C, is
recovered similarly to Mycobacterium avium complex (MAC)
under these conditions [8], so primary culture at higher temperature was not performed. Review of archived laboratory
procedures reveals minor changes in culture technique over
the study period that would not be expected to affect diagnostic yield or identification of NTM significantly. After 2014,
bone marrow cultures were additionally incubated in BACTEC
MYCO/F Lytic bottles. After 2013, the institution transitioned
from cotton swabs, from which mycobacteria were essentially
never recovered, to Copan eSwabs, from which mycobacteria
are rarely recovered. Throughout the study period, laboratory
policy was that tissue or fluid should be pursued over swabs as
the preferred diagnostic sample.
The AccuProbe system was used to identify M tuberculosis
to complex level, M avium/intracellulare to complex level, and
Mycobacterium gordonae (after 2006). If isolates were initially
probe-positive for MTC and Mycobacterium bovis infection
was suspected, further identification was made by biochemical
or genetic methods. After 2014, some MAC isolates were further identified as Mycobacterium chimaera using whole genome
sequencing at National Jewish Hospital. Otherwise, MTC and
MAC were not routinely identified to the species level. After
probes were performed, rapidly growing mycobacteria were
identified to group level by 3-day arylsulfatase and standardized growth studies. Subsequently, definitive identification was
performed by sending samples to ARUP Laboratories for identification of slow-growers other than MTC, the State Hygienic
Laboratory at the University of Iowa and the Centers for Disease
Control and Prevention for MTC with susceptibility testing,
and the University of Texas Health Science Center at Tyler for
identification of rapidly growing NTM by gene sequencing.
Data Collection

Review of the electronic medical record was performed on all
patients with at least 1 NTM culture isolate, as well as on patients
whose cultures grew M bovis. Although M bovis is a subspecies
of the MTC, an exception was made to include these cases in
the study because they were clinically significant, iatrogenic
infections from use of intravesical bacillus Calmette-Guerin
(BCG) for the treatment of bladder cancer. After detailed chart
review, cases were excluded from primary data analysis for 1
of 3 reasons: (1) insufficient information in the medical record
to diagnose infection (ie, limited/absent documentation of comorbid conditions, clinical presentation, treatment, or outcome
of NTM infection), (2) NTM culture isolate identified as a contaminant (defined as a single positive culture without clinical or
radiographic evidence of disease), or (3) NTM culture isolate
represented colonization (defined as repeat positive cultures
from the same specimen site without associated clinical or radiographic evidence of disease). All M gordonae isolates were
considered contaminants and excluded, because M gordonae is

the least pathogenic mycobacterial species and a frequent specimen contaminant in the hospital environment [9]. For patients
who had multiple NTM culture isolates from the same illness
episode, only the first isolate was included in data analysis.
Information collected during chart review included patient
demographics, relevant comorbid medical conditions (eg, HIV,
chronic lung disease, malignancy, transplant recipient), relevant
exposures (eg, recent travel, drug or tobacco use, recent healthcare interventions), and chronic medications, specifically focusing on immunosuppressive medications defined as systemic
corticosteroids at doses equivalent to ≥15 mg/day prednisone
for ≥1 month, tumor necrosis factor inhibitors, and a variety
of non-corticosteroid immunosuppressive agents including
immunophilin-binding drugs, antimetabolites, and alkylating
agents. We collected information on the clinical presentation
and longitudinal course of NTM infection, microbiologic data,
and any available laboratory, radiographic, and histopathologic
data. Finally, all available notes were reviewed to determine
the treatment regimen and clinical outcome for each patient.
Clinical outcomes were grouped into 3 categories based on
the most recent information in the medical record at the end
of the study period: resolution of infection, chronic/persistent
infection, and death. Cause of death was most commonly determined by clinical judgment of the primary medical team or
expert consultants caring for the patient at the time of death, as
documented in the medical record. In 4 cases, autopsy records
were available to determine cause of death.
Pulmonary Nontuberculous Mycobacteria Infection Definition

Cases of pulmonary NTM infection were diagnosed using
the American Thoracic Society/Infectious Diseases Society of
America (ATS/IDSA) diagnostic criteria [9], which require
clinical symptoms and signs of disease, radiographic evidence
of disease, and mycobacterial cultures to formulate diagnostic
criteria NTM lung disease. Clinical and microbiologic criteria
consist of positive culture results from ≥2 separate expectorated sputum samples or ≥1 bronchial wash or lavage. A single
investigator collected data from the medical record, reviewed
documentation by the patient’s primary team and/or expert consultants (eg, pulmonology, infectious diseases), and synthesized
this information to identify cases of pulmonary NTM infection
according to ATS/IDSA guidelines.
Extrapulmonary Nontuberculous Mycobacteria Infection Definition

We defined extrapulmonary infection as ≥1 positive culture
from an ordinarily sterile site with associated clinical evidence of
disease. Categories of extrapulmonary NTM infection included
SSTI, lymphadenitis, isolated bacteremia, ocular, sinus, genitourinary, gastrointestinal, intraperitoneal, intraarticular, and
bone infections, as well as disseminated disease. Classification
into a given category meant that all available microbiologic and
clinical information indicated that infection was limited to that

single organ system. Disseminated disease was defined as clinical, microbiologic, and/or radiographic evidence of NTM infection in at least 2 nonadjacent organ systems.
Data Analysis

Descriptive statistics were used to examine the frequency and
distribution of variables of interest. Multivariable logistic regression analyses were performed to assess for factors associated
with disseminated mycobacterial infection and mortality from
mycobacterial infection. We reached our final model using a
backwards elimination approach, retaining predetermined potential confounders (age and gender) and significant covariates
(P < .05 on the Wald test). Model fit was assessed using the
Hosmer-Lemeshow goodness-of-fit test. All statistical analyses
were performed using STATA 14 (STATA Corporation, College
Station, TX).
RESULTS

Between 1996 and 2017, the hospital laboratory identified 1064
positive NTM cultures, of which 139 were contaminants, 152
represented colonization, 337 were repeat positive cultures
from the same patient and illness, and 71 lacked sufficient information in the medical record to determine whether infection
was present (Figure 1). After exclusions, a total of 365 cases met
criteria for infection.
The age of patients meeting disease criteria (n = 365) ranged
from 1 to 95 years, with a median age of 55 years. Approximately
half (193 of 365; 52.9%) were female. Three hundred twenty-two
(88.2%) of the 365 patients were white, 15 (4.1%) were black, 10
(2.7%) were Hispanic, and 6 (1.6%) were Asian. Pulmonary disease predominated (185 of 365; 50.7%), followed by SSTI (56 of
365; 15.3%), disseminated disease (40 of 365; 11.0%), and lymphadenitis (28 of 365; 7.7%) (Table 1). Mycobacterium tuberculosis complex was the most common NTM isolate (184 of 365;
50.4%), followed by Mycobacterium chelonae (54 of 365; 14.8%),
Mycobacterium kansasii (21 of 365; 5.8%), Mycobacterium
abscessus (20 of 365; 5.5%), and Mycobacterium fortuitum (19 of
365; 5.2%). Females were disproportionately affected by MAC
(106 of 184; 57.6%) and M abscessus (14 of 20; 70%), whereas
males were more commonly affected by M kansasii (15 of
21; 71.4%).
Overall, 60 (60 of 365; 16.4%) patients died during the study
period, and NTM infection was considered the primary cause
of death in 63.3% (38 of 60) of cases. The majority of deaths
from NTM resulted from pulmonary and disseminated infections, with case-fatality rates of 10.8% and 50% during the
study period, respectively (Table 2). Patients who deceased
from mycobacterial infection were compared with patients
with NTM infection who deceased from other causes, recovered from infection, or remained stable with chronic infection. Patients whose outcomes were unknown (n = 50)
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Positive mycobacteria cultures
recorded in logging system
(N = 1199)
Excluded (n = 135)

Infection due to
Mycobacterium
tuberculosis

Patients
(n = 1064)
Excluded (n = 139)

Contaminant

Excluded (n = 337)

Repeat positive
culture from same
illness episode

Patients
(n = 925)

Patients
(n = 588)
Excluded (n = 71)

Insufficient information
available in the patient
medical record

Patients
(n = 517)
Excluded (n = 152)

Mycobacterial colonization,
not true infection

Patients
(n = 365)

Figure 1. Flowchart of patient selection. A logging system containing the medical record numbers of all patients between 1996 and 2017 at the University of Iowa Hospitals
and Clinics with cultures positive for Mycobacterium tuberculous or nontuberculous mycobacteria (NTM) was reviewed. Medical record review was performed on all patients
with cultures positive for NTM or Mycobacterium bovis. Infection was defined using the American Thoracic Society/Infectious Diseases Society of America (ATS/IDSA) NTM
lung disease guidelines. Contaminant was defined as a single positive culture without clinical or radiographic evidence of disease. Colonization was defined as ≥2 positive
cultures without clinical or radiographic evidence of disease. Cases were excluded if medical records lacked sufficient information to diagnose infection according to ATS/
IDSA guidelines. Cases of chronic NTM infection with multiple positive cultures were included only once in data analysis.

were excluded from analysis. The factors associated with
significantly increased odds of mortality from mycobacterial
infection were as follows: disseminated mycobacterial infection (odds ratio [OR], 5.0; 95% confidence interval [CI], 1.6–
15.0; P = .005), concomitant HIV infection (OR, 5.5; 95% CI,
1.4–21.6; P = .014), history of immunosuppressive therapy
(OR, 4.9; 95% CI, 1.9–12.9; P = .001), and history of unintentional weight loss at presentation (OR, 4.0; 95% CI, 1.5–10.4;
P = .005).
Pulmonary Disease

Pulmonary disease accounted for 50.7% (185 of 365) of infections, the majority of which were caused by MAC (127 of 185;
68.6%), then M kansasii (15 of 185; 8.1%) and M abscessus (14 of
4 • ofid • Hannah et al

185; 7.6%). Demographics of patients with pulmonary disease
were similar to the overall study population (Table 2). Sixtypercent (112 of 185; 60.5%) of patients with pulmonary NTM
infection had underlying structural lung disease, including 56
(56 of 185; 30.3%) with chronic obstructive pulmonary disease,
49 (49 of 185; 26.5%) with bronchiectasis, 14 (14 of 185; 7.6%)
with cystic fibrosis, 11 (11 of 185; 5.9%) with interstitial lung
disease, and 5 (5 of 185; 2.7%) with history of lung transplant.
The majority (101 of 185; 54.6%) of patients with pulmonary
disease were cigarette smokers, and 18.4% (34 of 185) were
taking ≥1 immunosuppressive medication at the time of diagnosis. When looking specifically at cases of MAC pulmonary
disease (MAC-PD) (n = 127), women were more commonly
affected (76 of 127; 59.8%). Less than half (35 of 76; 46.1%)

Table 1.

Frequency of Nontuberculous Mycobacteria Species by Disease Site

Organism
Mycobacterium avium complex

Pulmonary

SSTI

Lymphatic

Disseminated

Othera

Total

127

2

26

25

4

184 (50)

10

19

2

23

54 (15)

1

21 (6)

1

2

20 (5)

5

19 (5)

2

7

9 (2)

1

9 (2)

Mycobacterium chimaerab
Mycobacterium chelonae

4

Mycobacterium kansasii

15

5

Mycobacterium abscessus

14

3

Mycobacterium fortuitum

4

10

Mycobacterium bovis
Mycobacterium marinum
Mycobacterium xenopi

8
4

Mycobacterium mucogenicum

1

1

Mycobacterium NOS

5
5

Otherd

1

4

1

185 (51)

56 (15)

28 (8)

Total

0

6 (2)

4

6 (2)

2

6

15 (4)

4

1

10 (3)

2

Combinationc

2

4 (1)

2
40 (11)

56 (15)

8 (2)
365

Abbreviations: SSTI, skin/soft tissue infection; NOS, not otherwise specified.
NOTE: Values represent number of cases (%).
a

Includes ocular (n = 19), bacteremia (n = 15), sinus (n = 4), genitourinary (n = 6), intraperitoneal (n = 4), intraarticular (n = 4), bone (n = 2), and gastrointestinal (n = 2).

b

Mycobacterium chimaera is a member of the M avium complex but was separated for clarity.

c

Includes M avium complex/M chelonae (n = 6), M avium complex/M kansasii (n = 1), M chelonae/M abscessus (n = 1), M fortuitum/M kansasii (n = 1), and M mucogenicum/Mycobacterium
phocaicum (n = 1).

d

Includes Mycobacterium neoaurum (n = 2), Mycobacterium terrae complex (n = 2), Mycobacterium obuense (n = 1), Mycobacterium porcinum (n = 1), Mycobacterium scrofulaceum
(n = 1), and Mycobacterium smegmatis (n = 1).

of women with MAC-PD smoked cigarettes, compared with
68.6% (35 of 51) of men with MAC-PD.
The most common initial manifestations of pulmonary NTM
infection were cough, hemoptysis, weight loss, and fever. The
most common radiographic findings in patients with pulmonary NTM infection were fibrocavitary disease (observed in
52 patients), nodular/bronchiectatic disease (observed in 48
patients), and dense consolidation or solitary, noncavitating
mass (observed in 23 patients). Multifocal bronchiectasis alone
was observed in 33 patients with pulmonary NTM infection,
but the chronicity of radiographic bronchiectasis and whether
it preceded the diagnosis of NTM infection could not always
be determined. In women with MAC-PD (n = 76), nodular/
bronchiectatic radiographic findings were observed 50 patients,
and fibrocavitary changes were observed in 19 patients. For men
with MAC-PD (n = 51), 27 patients had nodular/bronchiectatic
radiographic findings, and 15 had fibrocavitary changes.
Of the patients who received medical treatment (117 of
185; 63.2%), antibiotic regimens typically included macrolide antibiotics (98 of 117; 83.8%), ethambutol (101 of 117;
86.3%), and rifamycin antibiotics (93 of 117; 79.5%). The majority (80 of 117; 68.4%) of patients who received treatment
were on anti-mycobacterial medications for ≥12 months,
with 1 patient on treatment for 11 years. Approximately one
third (60 of 185, 32.4%) of patients with pulmonary NTM had
full resolution of infection, 32.4% (60 of 185) had chronic infection, and 18.9% (35 of 185) died. Of the 35 patients who
died, NTM was identified as the underlying cause of death in
57.1% (20 of 35) of cases.

Skin/Soft Tissue Infection

There were 56 (56 of 365; 15.3%) SSTIs, the majority (33 of 56;
58.9%) of which occurred in females. Mycobacterium chelonae
was the most common organism (19 of 56; 33.9%), followed by
M fortuitum (10 of 56; 17.9%) and Mycobacterium marinum (8
of 56; 14.3%). Approximately half (29 of 56; 51.8%) of SSTIs occurred after documented injury to the skin. Fourteen SSTIs (14
of 56; 25%) were iatrogenic infections and occurred at the site of
injections, lines and catheters, surgical wounds, or medical implants. There were 15 cases of nonhealthcare-associated trauma
preceding SSTI, including gardening injuries, chemical burns,
intravenous drug use, tattoos, pedicures, and injuries while
cleaning fish tanks. Three of the 15 cases of nonhealthcareassociated trauma involved self-inflicted injuries in patients
who were diagnosed with factitious disorder imposed on self
(ie, Munchausen syndrome). In all 3 cases, patients presented
with recurrent, nonhealing SSTIs that were eventually attributed to self-injection of foreign substances including feces and
pond water.
The clinical manifestations of SSTIs were varied and included papules, plaques, nodules, abscesses, cellulitis, ulcers,
panniculitis, and 1 case of necrotizing fasciitis. The majority
(30 of 56; 53.6%) of SSTIs involved the upper extremities, 15
(15 of 56; 26.8%) involved the trunk, and 11 (11 of 56; 19.6%)
involved the lower extremities. Thirty-five (35 of 56; 62.5%) patients required surgical intervention to achieve disease resolution, ranging from simple surgical excision to limb amputation.
Full disease resolution was achieved in 83.9% (47 of 56) of cases.
One patient with a severe M abscessus SSTI at the exitsite of a
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Table 2.

Demographic and Clinical Characteristics of Patients by Infection Site

Characteristic

Pulmonary NTM
(n = 185)

Disseminated NTM
(n = 40)

Extrapulmonary NTMa
(n = 140)

Age (Years)
Median

63

42

44

Range

3–95

1–87

1–88

Gender
Female

101 (55)

13 (33)

79 (56)

Male

84 (45)

27 (68)

61 (44)

White

168 (91)

31 (78)

123 (88)

Black

4 (2)

7 (18)

4 (3)

Hispanic

3 (2)

1 (3)

6 (4)

Asian

6 (3)

0

0

Race

Comorbidities
Structural lung diseaseb

112 (61)

0

4 (3)

Solid malignancy

36 (19)

7 (18)

16 (11)

Hematologic malignancy

12 (6)

9 (23)

15 (11)

Solid organ transplant

8 (4)

2 (5)

4 (3)

Hematopoietic stem cell transplant

6 (3)

1 (3)

4 (3)

HIV

15 (8)

26 (65)

1 (1)

Iatrogenicc

1 (1)

9 (23)

50 (34)

Severe neutropeniad

2 (1)

5 (13)

3 (2)

Current smoker

101 (55)

20 (50)

34 (24)

Immunosuppressive medicatione

34 (18)

6 (15)

38 (27)

6 (3)

5 (13)

5 (4)

Medical

129 (70)

28 (70)

89 (64)

Surgical

13 (7)

5 (13)

92 (66)

Resolved

60 (32)

8 (20)

120 (86)

Persistent infection

60 (32)

3 (8)

4 (3)

Deceased from NTM

20 (11)

20 (50)

3 (2)

Risk factors

IV drug use
Treatmentf

Outcome

Abbreviations: HIV, human immunodeficiency virus; IV, intervenous; NTM, nontuberculous mycobacteria.
NOTE: Values represent number of patients (%).
a

Nondisseminated, extrapulmonary infections.

b

Chronic obstructive pulmonary disease, bronchiectasis, cystic fibrosis, interstitial lung disease.

c

Infections directly related to diagnostic and therapeutic procedures performed on the patient.

d

Absolute neutrophil count ≤500 cells/mm3.

e

Systemic corticosteroids at doses equivalent to ≥15 mg/day prednisone ≥1 month, tumor necrosis factor inhibitors, and noncorticosteroid immunosuppressive agents including
immunophilin-binding drugs, antimetabolites, and alkylating agents.
f

Indicates whether patients’ treatment course included antimicrobial therapy or surgical intervention. Patients could be included in more than 1 category.

percutaneous gastrostomy tube died from septic shock attributed to NTM infection.
Disseminated Disease

Of the 365 patients diagnosed with NTM infection, 40 (11.0%)
had disseminated infection. Mycobacterium avium complex
was identified in 25 of the 40 cases (62.5%), and an additional
4 patients with disseminated infection had cultures growing a
combination of MAC and M chelonae. Cultures were obtained
from a variety of sources, including bone marrow, stool, cerebrospinal fluid, peritoneal fluid, prostate tissue, abscesses, and
blood. The factors associated with significantly increased odds
of disseminated mycobacterial infection were HIV infection
6 • ofid • Hannah et al

(OR, 32.8; 95% CI, 12.8–84.2; P < .001) and having a history
of night sweats at presentation (OR, 4.3; 95% CI, 1.6–12.0;
P = .005). The presenting signs and symptoms of disseminated
disease most commonly included fever (25 of 40; 62.5%), weight
loss (14 of 40; 35%), and night sweats (13 of 40; 32.5%). Eleven
patients with disseminated NTM had pulmonary involvement
of disease; only 1 of these patients had fibrocavitary lung disease
on imaging, whereas the rest had a multifocal, reticulonodular
pattern.
Ninety-percent (36 of 40) of disseminated NTM infection developed in severely immunocompromised patients, including
26 (26 of 40; 65%) patients with HIV, all of whom had MAC
infection. For all 42 patients in this study with HIV, the median

CD4 count at the time of NTM infection diagnosis was 23 cells/
mm3 (interquartile range, 6–69). Other comorbidities in patients with disseminated infection included idiopathic CD4
lymphopenia, Mendelian susceptibility to mycobacterial diseases, acute leukemia, and severe neutropenia, defined as absolute neutrophil count <500 cells/mm3. As previously reported
by Marra et al [10], there were 4 cases of disseminated infection
caused by M chimaera, a MAC subspecies, in patients who had
been exposed to contaminated heater-cooler units used during
cardiothoracic surgery. There were 2 cases of disseminated infection from M bovis after intravesical BCG therapy for bladder
cancer.
Lymphadenitis

There were 28 cases of NTM lymphadenitis, and the majority
(26 of 28; 92.9%) of patients were ≤6 years of age. Twenty
(71.4%) of the 28 patients were female. Only 2 adult patients
were diagnosed with isolated lymphadenitis, both of whom
were severely immunocompromised. Twenty-six (92.9%) of
the 28 cases were caused by MAC; the remaining 2 cases were
caused by Mycobacterium scrofulaceum and M xenopi. All patients presented with a progressively enlarging head/neck mass,
often with overlying erythematous skin changes. Swelling was
painless in 24 of 28 cases. Fever was reported in only 2 patients.
All cases of lymphadenitis occurred in the head/neck region
and involved either cervical (16 of 28; 57.1%), submandibular
(7 of 28; 25.0%), or preauricular (5 of 28; 17.9%) lymph nodes.
All patients required surgical excision of the infected node, and
8 (8 of 28; 28.6%) received adjuvant anti-mycobacterial therapy;
the median duration of therapy in these patients was 2 months.
All cases of lymphadenitis fully resolved with treatment.
DISCUSSION

This study represents one of the largest retrospective chart reviews on NTM infections in a cohort of patients diagnosed at a
Midwestern facility over the course of 2 decades. By reviewing
medical records, we were able to correlate NTM cultures with
clinical and radiographic data to identify clinically significant
NTM infection using the ATS/IDSA diagnostic criteria [11].
The findings in this study were consistent with US NTM disease patterns reported in the literature, particularly regarding
patient demographics, risk factors, organism, and organ involvement. We identified MAC as the most common organism
and pulmonary disease as the most common site of infection.
These findings reflect the fact that MAC-PD is the most prevalent NTM infection worldwide [7, 11, 12, 13]. The prevalence of
MAC compared with other NTM species is not completely understood but may be a result of its ability to form biofilms, high
innate chlorine and biocide resistance, and tolerance of extraordinarily low nutrient levels and temperature extremes. These
features allow MAC to persist in both treated and untreated

water sources, which then presumably leads to human exposure through drinking, bathing, and swimming [14]. There are
2 prototypical phenotypes for MAC-PD: (1) slowly progressive
nodular bronchiectatic disease in postmenopausal, nonsmoking
females (“Lady Windermere syndrome”) [15] and (2) rapidly
progressive fibrocavitary disease in older males with underlying
smoking-related lung disease [16]. In accordance with these
classic phenotypes, we found that MAC-PD was more common
in women, the majority of whom were nonsmokers, whereas
most men with MAC-PD were smokers. In this study population, nodular/bronchiectatic changes were the most common
radiographic finding in MAC-PD for both men and women.
After lung disease, we identified SSTIs as the most frequent
manifestation of NTM infection. The incidence of cutaneous
NTM appears to be increasing [17]. Although NTM SSTIs typically remain localized to the skin/soft tissues, they typically
have a protracted clinical course requiring surgical interventions and multidrug regimens. Similar to findings from a recent retrospective case series on cutaneous NTM by Philips
et al [18], we found that SSTIs were most commonly caused by
rapid-growing NTM species (ie, M chelonae, M fortuitum), as
well as the slow-grower M marinum. One significant finding
from our cohort was that 1 in 4 SSTIs were considered nosocomial infections. We also identified iatrogenic infections of the
bloodstream, eye, urinary tract, joint, bone, and intraperitoneal
space, as well as disseminated disease from M chimaera.
Prevention of nosocomial NTM is challenging when so little
is known on the mechanism of disease acquisition and pathophysiology [11]. Currently, water sources, particularly tap
water, pose the greatest risk for healthcare-associated NTM infections, particularly SSTIs. The use of hospital tap water during
any sterile or nonsterile procedure should be avoided to prevent
healthcare-associated NTM outbreaks [11].
The majority of patients in our cohort were >50 years old,
reflecting the strong association between aging and NTM infection [7, 12]. This association may be due to decreased efficiency of cell-mediated immunity, as well structural and
functional changes in organ systems that occur with aging [19].
Regardless of the affected organ system, most patients in our
cohort had pre-existing structural, immunologic, or genetic
abnormalities that conferred increased risk for infection, such
as structural lung disease in patients who acquired pulmonary
infections, physical tissue trauma preceding the development
of SSTIs, and patients with HIV who developed disseminated
NTM. Increased prevalence of NTM infection in patients with
predisposing factors is well documented in the literature [1].
Szymanski et al [20] suggested that even in otherwise healthy
patients with NTM pulmonary disease, there are multiple underlying genetic variants that may increase susceptibility to
infection.
Although aging, medical comorbidities, and immunodeficiencies are major risk factors for NTM infection, Al-Houqani
Characteristics of Nontuberculous Mycobacterial Infections • ofid • 7

et al [21] demonstrated that these factors only partly account
for the increasing prevalence of NTM disease. There are likely
unknown environmental and/or pathogen-specific factors
that are also contributing to increased disease prevalence.
This concept is demonstrated in the epidemiology of NTM
lymphatic infections. Mycobacterial lymphadenitis is a relatively common pediatric infection that typically occurs in otherwise healthy children. The prevailing theory is that children
acquire NTM from drinking water and/or frequent hand-tomouth contact with NTM in soil [11, 22]. Historically, M
scrofulaceum was the most common cause of NTM lymphadenitis in the United States until approximately 1975, when
rates of M scrofulaceum sharply declined and MAC became
the predominant cause of infection [14]. Primm et al [14]
proposed that this shift may have resulted from the implementation of the Clean Water Act in 1972, when increased
use of chlorination of public water supplies allowed chlorineresistant NTM species (ie, MAC) to persist, whereas the more
chloride-susceptible M scrofulaceum became less prevalent
[14, 23]. This is reflected in our cohort, where almost all cases
of lymphadenitis were caused by MAC and only 1 was from M
scrofulaceum. Environmental and pathogen-specific factors
may also explain the geographical differences in NTM species worldwide [14]. Similar to other North American-based
studies, we found that M chelonae, M kansasii, M abscessus,
and M fortuitum were the most common causes of infection
after MAC, whereas Mycobacterium malmoense, M xenopi,
and M scrofulaceum predominate in other parts of the world
[7, 11, 24]. In addition to worldwide differences in NTM species, Spaulding et al [24] demonstrated that there are likely
differences in geographical distribution even within the
United States. They found that MAC is more frequently identified in NTM isolates in the South and Northeast, whereas
other regions, such as Iowa, have proportionally higher frequencies of M abscessus/M chelonae isolates.
Limitations of this study are similar to the limitations of
other epidemiologic studies of NTM and include lack of
consensus on diagnostic criteria for extrapulmonary disease
and microbiologic challenges with accurate identification
and speciation of mycobacteria. Positive cultures for NTM
must be interpreted with caution, with consideration of specimen source and organism virulence. When synthesizing information from the medical records of patients with positive
NTM cultures, it can be difficult to differentiate between
cases of transient infection, true infection, colonization, and
contamination, particularly in complex, systemically unwell
patients with multiple medical comorbidities. Our findings
were also limited by the retrospective nature of the study,
the fact that data were collected from a single institution,
and the fact that cases identified using nonculture methods
(ie, polymerase chain reaction-based methods) were excluded from the study.
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CONCLUSIONS

This retrospective chart review represents one of the largest reviews of clinical, radiographic, and microbiologic
findings of NTM infections, providing a broad overview
of the demographics and clinical manifestations of pulmonary and extrapulmonary NTM infections and contributing to the body of knowledge on this clinically
significant yet poorly understood class of organisms.
Nontuberculous mycobacteria infections pose a serious
threat to patients and may risk development of antimicrobial resistance, particularly given that these diseases are
notoriously challenging to recognize, diagnose, and treat
in a timely manner, if at all [25]. Even within NTM disease
states, (1) decisions to manage medically versus surgically
and (2) antimicrobial therapeutic selections vary widely,
making understanding the epidemiology of infection critical to improving patient outcomes. The most pressing
issue in understanding NTM disease is the need for comprehensive surveillance efforts and systematic epidemiologic studies, which could be more readily performed if
isolation of NTM or diagnosis of NTM disease were reportable to public health authorities, such as is required
in the states of Oregon and Tennessee. In addition, further
studies are needed to validate the use of the ATS/IDSA diagnostic criteria as well as to develop guidelines for the
diagnosis and treatment of extrapulmonary infections.
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